Hướng tới các insulin có tác dụng kéo dài, không đỉnh và có thể tái tạo được. Đánh giá các chế phẩm insulin cơ sở dựa trên các nghiên cứu clamp isoglycaemic
Tóm tắt
Từ khóa
Tài liệu tham khảo
Rosskamp RH, 1999, Long‐acting insulin analogs, Diabetes Care, 22, B109
EMEA/CPMP.Note for Guidance on clinical investigation of medicinal products in the treatment of diabetes mellitus (London 30 May 2002 CPMP/EWP/1080/00). Available from URL:http://www.emea.eu.int/pdfs/human/ewp/108000en.pdf. Accessed 10 April 2007.
Porcellati F, 2006, Pharmacokinetics and ‐dynamics of therapeutic doses of the ‘long‐acting’ insulin analogues glargine and detemir at steady‐state in type 1 diabetes, Diabet Med, 23, 341
Heinemann L, 1998, Pharmacokinetics and metabolism of insulin lispro, Insulin Lispro: A New Rapid-acting Insulin Analog, Chapter III. Drugs Today (Barc), 34, 23
Nosek L, 2003, No increase in the duration of action with rising doses of insulin aspart, Diabetes, 52, 551
Lauritzen T, 1985, Pharmacokinetic and clinical aspects of intensified subcutaneous insulin therapy, Dan Med Bull, 32, 104
Dornhorst A, 2006, Initiating insulin detemir improves glycaemic control without weight gain in OAD‐treated, insulin naive patients with type 2 diabetes: results from the PREDICTIVE™ study, Diabet Med, 23, 136
Tsur A, 2006, Switching from premix insulin to BB therapy with insulin detemir and insulin aspart improves glycaemic control and reduces hypoglycaemia, without weight gain, in type 2 patients: 3‐month results from the PREDICTIVE™ study, Diabet Med, 23, 347
Pieber TR, 2005, Insulin therapy in type 1 diabetes – insulin detemir plus insulin aspart is associated with less risk of major as well as nocturnal hypoglycaemia than insulin glargine plus insulin aspart at comparable levels of glycaemic control in type 1 diabetes, Diabetologia, 48
Porcellati F, 2005, Optimized use of insulin glargine in intensive treatment of type 1 diabetes mellitus: benefits and a new question, Diabetes, 54, 524
Le Floch J, 2006, Interim results of a French multi‐centre trial comparing insulin detemir once daily vs. twice daily in people with type 1 diabetes: the ADAPT study, Diabet Med, 23
Gallwitz B, 2006, Switching from a human to an insulin analogue BB regimen with insulin detemir/insulin aspart improves glycaemic control and reduces hypoglycaemic episodes in type 1 patients: results from the PREDICTIVETM study, Diabet Med, 23
Rosenstock J, 2006, Insulin detemir added to oral anti‐diabetic drugs in type 2 diabetes provides glycemic control comparable to insulin glargine with less weight gain, Diabetes, 55, 555